Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenic mechanisms mediating antiphospholipid syndrome.

P L Meroni1, P Riboldi

  • 1Allergy and Clinical Immunology Unit, IRCCS Istituto Auxologico Italiano, Department of Internal Medicine, University of Milan, Italy. pierluigi.meroni@unimi.it

Current Opinion in Rheumatology
|October 18, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6<sup>+</sup>B helper T cells in systemic lupus erythematosus.

Proceedings of the National Academy of Sciences of the United States of America·2020
Same author

Unmet Needs in the Treatment of RA in the Era of Jak-i: IDRA (Italian Delphi Rheumatoid Arthritis) Consensus.

BioMed research international·2018
Same author

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

BJOG : an international journal of obstetrics and gynaecology·2018
Same author

Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?

Autoimmunity reviews·2017
Same author

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

Lupus·2016
Same author

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Annals of the rheumatic diseases·2016

Antiphospholipid antibodies, markers for antiphospholipid syndrome, contribute to blood clots and pregnancy complications. They may affect cellular functions, explaining clotting test paradoxes and thrombosis risks.

Area of Science:

  • Immunology
  • Hematology
  • Obstetrics

Background:

  • Antiphospholipid antibodies (aPL) are diagnostic markers for antiphospholipid syndrome (APS).
  • aPL are implicated in thrombotic diathesis and obstetrical complications.
  • The precise mechanisms underlying aPL-associated pathology are under investigation.

Purpose of the Study:

  • To explore the role of antiphospholipid antibodies in coagulation homeostasis.
  • To investigate the cellular effects of antiphospholipid antibodies.
  • To elucidate the mechanisms behind the clinical manifestations of antiphospholipid syndrome.

Main Methods:

  • Review of in vitro and in vivo experimental models.
  • Analysis of human studies investigating cellular interactions.

Related Experiment Videos

  • Examination of the role of phospholipid-binding proteins like beta 2 -glycoprotein I.

    • Main Results:

    • Antiphospholipid antibodies modulate the function of cells involved in coagulation.
    • This modulation offers a new hypothesis for prolonged in vitro coagulation assays and in vivo thrombosis.
    • Obstetrical complications may stem from direct antibody effects on trophoblasts, independent of thrombosis.

    Conclusions:

    • Antiphospholipid antibodies have direct cellular effects beyond interaction with soluble coagulation factors.
    • Beta 2 -glycoprotein I acts as a bridge between antibodies and cellular targets.
    • These findings provide a unified hypothesis for the diverse manifestations of antiphospholipid syndrome.